Clinical Trial Update: A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating pregabalin for moderate to severe chronic bone pain due to metastatic cancer was terminated, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Neoplasms
• Cancer
• Pain Intractable

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Bone Neoplasms, Pain, Intractable | Phase 4 | Status: TERMINATED | Results posted: 2011-09-27